Lactulose ingestion causes an increase in the abundance of gut-resident bifidobacteria in Japanese women: a randomised, double-blind, placebo-controlled crossover trial
- 24 February 2021
- journal article
- research article
- Published by Wageningen Academic Publishers in Beneficial Microbes
- Vol. 12 (1), 43-53
- https://doi.org/10.3920/bm2020.0100
Abstract
The genus Bifidobacterium comprises various bacterial species, and the complement of species within the human intestinal tract differs from individual to individual. The balance of these bifidobacterial species remains poorly understood, although it is known that the abundance of bifidobacteria increases following the ingestion of prebiotics. We previously conducted a randomised, placebo-controlled, double-blind, crossover study of 2 g/day lactulose ingestion for 2 weeks in 60 Japanese women. To study the effect of lactulose ingestion on each bifidobacterial species, here, we measured the abundance of each of the principal bifidobacterial species. After lactulose ingestion, the log cell counts of the Bifidobacterium adolescentis group (8.97±0.08 vs 9.39±0.08, P=0.0019), Bifidobacterium catenulatum group (9.45±0.10 vs 9.65±0.10, P=0.0032) and Bifidobacterium longum group (9.01±0.07 vs 9.29±0.07, P=0.0012) were significantly higher than in the placebo ingestion control group. However, the log cell counts were similar for Bifidobacterium breve (8.12±0.12 vs 8.33±0.12, P=0.20), Bifidobacterium bifidum (9.08±0.12 vs 9.42±0.14, P=0.095) and Bifidobacterium animalis subspecies lactis (8.65±0.53 vs 8.46±0.46, P=0.77). Cluster analysis of the log cell count data at the bifidobacterial species level revealed three distinct clusters, but the combinations and ratios of the constituent bifidobacteria were not affected by lactulose ingestion. Furthermore, principal coordinate analysis of the intestinal microbiota in the lactulose and placebo ingestion groups using Illumina MiSeq showed no significant differences in the intestinal microbiota as a whole. These results suggest that 2 g/day lactulose ingestion for 2 weeks significantly increases the abundance of intestinal bifidobacteria, but does not affect the intestinal microbiota as a whole.Keywords
This publication has 21 references indexed in Scilit:
- Differences in folate production by bifidobacteria of different originsBioscience of Microbiota, Food and Health, 2015
- On comparison of SAS codes with GLM and MIXED for the crossover studies with QT interval dataTranslational and Clinical Pharmacology, 2014
- Molecular Monitoring of the Fecal Microbiota of Healthy Human Subjects during Administration of Lactulose and Saccharomyces boulardiiApplied and Environmental Microbiology, 2006
- Lactulose ingestion increases faecal bifidobacterial counts: A randomised double-blind study in healthy humansEuropean Journal of Clinical Nutrition, 2004
- Quantitative PCR with 16S rRNA-Gene-Targeted Species-Specific Primers for Analysis of Human Intestinal BifidobacteriaApplied and Environmental Microbiology, 2004
- A Human Volunteer Study to Determine the Prebiotic Effects of Lactulose Powder on Human Colonic MicrobiotaMicrobial Ecology in Health & Disease, 2002
- Specific Identification and Targeted Characterization of Bifidobacterium lactis from Different Environmental Isolates by a Combined Multiplex-PCR ApproachApplied and Environmental Microbiology, 2001
- Rapid identification of human intestinal bifidobacteria by 16S rRNA-targeted species- and group-specific primersFEMS Microbiology Letters, 1998
- Effect of Yogurt and Yogurt Supplemented with Bifidobacterium and/or Lactulose in Healthy Persons: A Comparative StudyBifidobacteria and Microflora, 1991
- Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry deviceGut, 1974